Clinical Trial Update: Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating mecobalamin with anti-VEGF intravitreal injections for retinal vein occlusion. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Mecobalamin (mecobalamin)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Retinal Vein Occlusion (RVO) | Phase 4 | Status: RECRUITING